106 results on '"Mufti, G."'
Search Results
2. FLAG-lite regimen is effective bridging salvage chemotherapy for relapsed/refractory acute myeloid Leukaemia - a single centre experience: 336
3. Germline mutations of hTERT in myelodysplastic syndromes are associated with shortened telomeres but are not associated with increased cytogenetic abnormalities: 298
4. A comparison of PCR methods for the detection of MYD88 L265P mutations in a diagnostic setting: 193
5. T-cell depletion with anti-thymocyte globulin (ATG) favours superior overall survival and lowers rates of relapse and GVHD when compared to alemtuzumab in patients undergoing allogeneic haematopoietic stem cell transplantation for myelofibrosis: A retrospective single centre analysis: 21
6. Single UK centre outcomes of peripheral blood stem cell (PBSC) haploidentical transplantation: 20
7. Feasibility and optimal schedule of eculizumab in patients with haemolytic paroxysmal nocturnal hemoglobinuria (hPNH) with severe aplastic anaemia (SAA) prior to haemopoietic stem cell transplant (HSCT): 22
8. Targeted sequencing of 647 patients with myeloid malignancies, marrow failures and cytopenia: A prospective ‘real life’ analysis: 17
9. Donor lymphocyte infusion - a retrospective single centre audit: 13
10. Immunological profile of patients after HSCT using the FCC conditioning regimen for treatment of severe aplastic anemia indicates potential basis for tolerance with mixed T-cell chimerism and extremely low incidence of GvHD: 12
11. Peptide vaccination using combined adjuvants for synergistic activation of cellular immunity (CASAC) promotes potent WT1-specific immune responses in an in vivo mouse model: 38
12. Autoimmune haemolytic anaemia after allogeneic haematopoietic stem cell transplantation: analysis of 555 transplant patients at Kingʼs College Hospital: 37
13. Eculizumab in paroxysmal nocturnal haemoglobinuria (PNH): a report of all 153 patients treated in the UK: 8
14. A comprehensive diagnostic approach improves the diagnostic accuracy of invasive fungal disease (IFD) in adult haemato-oncology patients undergoing HSCT or high dose chemotherapy - results of the Kingʼs Prospective Aspergillosis Study (NCT00816088): 5
15. Video-assisted thoracoscopic (VATS) biopsy is feasible and safe in adult haemato-oncology patients undergoing stem cell transplantation or high dose chemotherapy: 35
16. Separation of cell cycle and growth cycle programmes in primary human T cells: 42
17. Epigenetic code of primary human T cells during the first cell cycle: 216
18. Outcomes of MDS patients with chromosome 7 abnormalities treated with 5-azacytidine: 157
19. Systems biology analysis of the G0-G1 cell cycle transition of human primary T cells: 238
20. Use of quantitative PCR approaches to predict relapse and direct molecularly targeted therapy with arsenic trioxide (ATO) in acute promyelocytic leukaemia (APL): 116
21. RITUXIMAB SALVAGE FOLLOWING RELAPSE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION FOR NON-HODGKIN'S LYMPHOMA
22. 'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins
23. ABSENCE OF COSTIMULATION AND SECRETION OF TH1 CYTOKINE INHIBITORS CONTRIBUTE TO EVASION OF ANTI-LEUKAEMIC IMMUNITY
24. POSITRON EMISSION SCANNING WITH 18-FDG IN THE DIAGNOSIS OF DEEP FUNGAL INFECTIONS
25. INEFFECTIVE HAEMOPOIESIS AND APOPTOSIS IN MYELODYSPLASTIC SYNDROMES
26. Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies
27. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia
28. Familial MDS with 5q — abnormality
29. A pilot study of low-dose recombinant human granulocyte-macrophage colony-stimulating factor in chronic neutropenia
30. MANAGEMENT OF MYELODYSPLASTIC SYNDROMES
31. Detection of HIV in haemopoietic progenitors
32. Primary myelodysplastic syndrome in children: the clinical experience in 33 cases
33. Clinicopathological features of acute undifferentiated leukaemia with a stem cell phenotype
34. PRODROMAL CUTANEOUS VASCULITIS IN MYELODYSPLASTIC SYNDROMES
35. TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKAEMIA WITH LOW DOSE ETOPOSIDE.
36. Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases.
37. Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival.
38. Immunological abnormalities in myelodysplastic syndromes I. SERUM IMMUNOGLOBULINS AND AUTOANTIBODIES.
39. Immunological abnormalities in myelodysplastic syndromes II. COEXISTENT LYMPHOID OR PLASMA CELL NEOPLASMS: A REPORT OF 20 CASES UNRELATED TO CHEMOTHERAPY.
40. Myelodysplastic syndromes: a scoring system with prognostic significance.
41. Serous effusions in monocytic leukaemias.
42. Coexistent myelodysplasia and plasma cell neoplasia.
43. COEXISTENT LYMPHOID OR PLASMA CELL NEOPLASMS
44. Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT
45. Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline.
46. British Society for Haematology guidelines for the management of adult myelodysplastic syndromes.
47. British Society for Haematology guidelines for the diagnosis and evaluation of prognosis of Adult Myelodysplastic Syndromes.
48. British Committee for Standards in Haematology guidelines for aplastic anemia: Single centre retrospective review finds no compelling evidence for the recommended higher platelet count threshold of 20 × 10 9 /L - RESPONSE to Yan et al.
49. Guidelines for the diagnosis and management of adult aplastic anaemia.
50. Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.